Capecitabine in Treating Patients With Metastatic Breast Cancer

NCT00274768 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: capecitabine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]